Cytokine genes TNF, IL1A, IL1B, IL6, IL1RN and IL10, and childhood-onset mood disorders

Neuropsychobiology

Volumn 58, Issue 2, 2008, Pages 71-80

  Misener, V L ^a   Gomez, L ^a   Wigg, K G ^a   Luca, P ^a   King, N ^b   Kiss, E ^d   Daroczi G ^d   Kapornai, K ^d   Tamas, Z ^e   Mayer, L ^e   Gadoros J ^e   Baji, I ^e   Kennedy, J L ^b   Kovacs, M ^f   Vetro A ^d   Barr, C L ^a,c,i   Benák, István ^g   Osváth, Viola Kothencné ^g   Dombovári, Edit ^g   Kaczvinszky, Emília ^g   Mayer, László ^g   Gádoros, Júlia ^e   Baji, Ildikó ^e   Tamás, Zsuzsa ^e   Besnyo, Márta ^e   Székely, Judit ^h   more..

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF SZEGED   (Hungary)

^e Vadaskert Hospital   (Hungary)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF SZEGED   (Hungary)

^h SEMMELWEIS UNIVERSITY   (Hungary)

ⁱ TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Depression, childhood; Inflammatory cytokines; Mood disorders, genetic associations

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR;

ADOLESCENT; ALLELE; ARTICLE; CHILDHOOD DISEASE; DEPRESSION; FAMILY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; ONSET AGE; PRIORITY JOURNAL; PROGENY; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

CHILD; CYTOKINES; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MOOD DISORDERS; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 52849101341     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000159775     Document Type: Article

References (123)

1. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW: From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-56.
2. Smith RS: The macrophage theory of depression. Med Hypotheses 1991;35:298-306.
3. Charlton BG: The malaise theory of depression: major depressive disorder is sickness behavior and antidepressants are analgesic. Med Hypotheses 2000;54:126-130.
4. Dunn AJ, Swiergiel AH, de Beaurepaire R: Cytokines as mediators of depression: what can we learn from animal studies? Neurosci Biobehav Rev 2005;29:891-909.
5. Raison CL, Capuron L, Miller AH: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31.
6. Hashimoto K, Shimizu E, Iyo M: Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 2004;45:104-114.
7. Campbell S, Macqueen G: The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci 2004;29:417-426.
8. Ressler KJ, Nemeroff CB: Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 2000;12:2-19.
9. Barrientos RM, Sprunger DB, Campeau S, Higgins EA, Watkins LR, Rudy JW, Maier SF: Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience 2003;121:847-853.
10. Kaneko N, Kudo K, Mabuchi T, Takemoto K, Fujimaki K, Wati H, Iguchi H, Tezuka H, Kanba S: Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus. Neuropsychopharmacology 2006;31:2619-2626.
11. Myint AM, Kim YK: Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 2003;61:519-525.
12. Hayley S, Poulter MO, Merali Z, Anisman H: The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 2005;135:659-678.
13. Haddad JJ, Saade NE, Safieh-Garabedian B: Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary- adrenal revolving axis. J Neuroimmunol 2002;133:1-19.
14. Timonen M, Jokelainen J, Hakko H, Silvennoinen-Kassinen S, Meyer-Rochow VB, Herva A, Rasanen P: Atopy and depression: results from the Northern Finland 1966 Birth Cohort Study. Mol Psychiatry 2003;8:738-744.
15. Slattery MJ: Psychiatric comorbidity associated with atopic disorders in children and adolescents. Immunol Allergy Clin North Am 2005;25:407-420.
16. Dickens C, Creed F: The burden of depression in patients with rheumatoid arthritis. Rheumatology (Oxford) 2001;40:1327-1330.
17. Rudisch B, Nemeroff CB: Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 2003;54:227-240.
18. Capuron L, Miller AH: Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 2004;56:819-824.
19. Brambilla F, Monteleone P, Maj M: Interleukin-1beta and tumor necrosis factor-alpha in children with major depressive disorder or dysthymia. J Affect Disord 2004;78:273-277.
20. Suarez EC, Krishnan RR, Lewis JG: The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. Psychosom Med 2003;65:362-368.
21. Suarez EC, Lewis JG, Krishnan RR, Young KH: Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuro-endocrinology 2004;29:1119-1128.
22. Mendlewicz J, Kriwin P, Oswald P, Souery D, Alboni S, Brunello N: Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. Int Clin Psychopharmacol 2006;21:227-231.
23. Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B, Spellmann I, Hetzel G, Maino K, Kleindienst N, Moller HJ, Arolt V, Riedel M: The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 2006;11:680-684.
24. Calder PC: Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids 2006;75:197-202.
25. Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, Keck PE Jr, Marangell LB, Richardson AJ, Lake J, Stoll AL: Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 2006;67:1954-1967.
26. Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH: Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry 2006;163:1098-1100.
27. Sullivan PF, Neale MC, Kendler KS: Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000;157:1552-1562.
28. Craddock N, Forty L: Genetics of affective (mood) disorders. Eur J Hum Genet 2006;14:660-668.
29. Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Hohler T: Differential regulation of interleukin-10 production by genetic and environmental factors - a twin study. Genes Immun 2002;3:407-413.
30. de Craen AJ, Posthuma D, Remarque EJ, van den Biggelaar AH, Westendorp RG, Boomsma DI: Heritability estimates of innate immunity: an extended twin study. Genes Immun 2005;6:167-170.
31. Posthuma D, Meulenbelt I, de Craen AJ, de Geus EJ, Slagboom PE, Boomsma DI, Westendorp RG: Human cytokine response to ex vivo amyloid-beta stimulation is mediated by genetic factors. Twin Res Hum Genet 2005;8:132-137.
32. Hohler T, Reuss E, Adams P, Bartsch B, Weigmann B, Worns M, Galle PR, Victor A, Neurath MF: A genetic basis for IFN-γ production and T-bet expression in humans. J Immunol 2005;175:5457-5462.
33. Worns MA, Victor A, Galle PR, Hohler T: Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels - a study in twins. Genes Immun 2006;7:600-605.
34. McCaffery JM, Frasure-Smith N, Dube MP, Theroux P, Rouleau GA, Duan Q, Lesperance F: Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med 2006;68:187-200.
35. Wamboldt MZ, Schmitz S, Mrazek D: Genetic association between atopy and behavioral symptoms in middle childhood. J Child Psychol Psychiatry 1998;39:1007-1016.
36. Wamboldt MZ, Hewitt JK, Schmitz S, Wamboldt FS, Rasanen M, Koskenvuo M, Romanov K, Varjonen J, Kaprio J: Familial association between allergic disorders and depression in adult Finnish twins. Am J Med Genet 2000;96:146-153.
37. Wamboldt MZ, Schmitz S, Mrazek D: Genetic association between atopy and behavioral symptoms in middle childhood (corrigendum). J Child Psychol Psychiatry 2000;41:674.
38. Pessi T, Karjalainen J, Hulkkonen J, Nieminen MM, Hurme M: A common IL-1 complex haplotype is associated with an increased risk of atopy. J Med Genet 2003;40:e66.
39. Gentile DA, Doyle WJ, Zeevi A, Howe-Adams J, Trecki J, Skoner DP: Association between TNF-α and TGF-β genotypes in infants and parental history of allergic rhinitis and asthma. Hum Immunol 2004;65:347-351.
40. Ober C, Hoffjan S: Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun 2006;7:95-100.
41. Sohn MH, Song JS, Kim KW, Kim ES, Kim KE, Lee JM: Association of interleukin-10 gene promoter polymorphism in children with atopic dermatitis. J Pediatr 2007;150:106-108.
42. Rice F, Harold G, Thapar A: The genetic aetiology of childhood depression: a review. J Child Psychol Psychiatry 2002;43:65-79.
43. Rice F, Harold GT, Thapar A: Assessing the effects of age, sex and shared environment on the genetic aetiology of depression in childhood and adolescence. J Child Psychol Psychiatry 2002;43:1039-1051.
44. Gjone H, Stevenson J, Sundet JM, Eilertsen DE: Changes in heritability across increasing levels of behavior problems in young twins. Behav Genet 1996;26:419-426.
45. Eley TC, Stevenson J: Exploring the covariation between anxiety and depression symptoms: a genetic analysis of the effects of age and sex. J Child Psychol Psychiatry 1999;40:1273-1282.
46. Rende RD, Plomin R, Reiss D, Hetherington EM: Genetic and environmental influences on depressive symptomatology in adolescence: individual differences and extreme scores. J Child Psychol Psychiatry 1993;34:1387-1398.
47. Happonen M, Pulkkinen L, Kaprio J, Van der Meere J, Viken RJ, Rose RJ: The heritability of depressive symptoms: multiple informants and multiple measures. J Child Psychol Psychiatry 2002;43:471-479.
48. Boomsma DI, van Beijsterveldt CE, Hudziak JJ: Genetic and environmental influences on anxious/depression during childhood: a study from the Netherlands Twin Register. Genes Brain Behav 2005;4:466-481.
49. Eaves LJ, Silberg JL, Meyer JM, Maes HH, Simonoff E, Pickles A, Rutter M, Neale MC, Reynolds CA, Erikson MT, Heath AC, Loeber R, Truett KR, Hewitt JK: Genetics and developmental psychopathology. 2. The main effects of genes and environment on behavioral problems in the Virginia Twin Study of Adolescent Behavioral Development. J Child Psychol Psychiatry 1997;38:965-980.
50. Lau JY, Eley TC: Changes in genetic and environmental influences on depressive symptoms across adolescence and young adulthood. Br J Psychiatry 2006;189:422-427.
51. Scourfield J, Rice F, Thapar A, Harold GT, Martin N, McGuffin P: Depressive symptoms in children and adolescents: changing aetiological influences with development. J Child Psychol Psychiatry 2003;44:968-976.
52. Thapar A, McGuffin P: A twin study of depressive symptoms in childhood. Br J Psychiatry 1994;165:259-265.
53. Schmitz S, Fulker DW, Mrazek DA: Problem behavior in early and middle childhood: an initial behavior genetic analysis. J Child Psychol Psychiatry 1995;36:1443-1458.
54. Edelbrock C, Rende R, Plomin R, Thompson LA: A twin study of competence and problem behavior in childhood and early adolescence. J Child Psychol Psychiatry 1995;36:775-785.
55. Hudziak JJ, Rudiger LP, Neale MC, Heath AC, Todd RD: A twin study of inattentive, aggressive, and anxious/depressed behaviors. J Am Acad Child Adolesc Psychiatry 2000;39:469-476.
56. Cho H, Guo G, Iritani BJ, Hallfors DD: Genetic contribution to suicidal behaviors and associated risk factors among adolescents in the US. Prev Sci 2006;7:303-311.
57. Bayley JP, Ottenhoff TH, Verweij CL: Is there a future for TNF promoter polymorphisms? Genes Immun 2004;5:315-329.
58. Hegedus CM, Skibola CF, Bracci P, Holly EA, Smith MT: Screening the human serum proteome for genotype-phenotype associations: an analysis of the IL6 -174G>C polymorphism. Proteomics 2007;7:548-557.
59. Witkin SS, Gerber S, Ledger WJ: Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 2002;34:204-209.
60. Opdal SH: IL-10 gene polymorphisms in infectious disease and SIDS. FEMS Immunol Med Microbiol 2004;42:48-52.
61. Ewens WJ, Spielman RS: The transmission/disequilibrium test; in Balding DJ (ed): Handbook of Statistical Genetics. Chichester, Wiley & Sons, 2001, pp 507-518.
62. Vuga M, Fox NA, Cohn JF, George CJ, Levenstein RM, Kovacs M: Long-term stability of frontal electroencephalographic asymmetry in adults with a history of depression and controls. Int J Psychophysiol 2006;59:107-115.
63. Silk JS, Shaw DS, Skuban EM, Oland AA, Kovacs M: Emotion regulation strategies in offspring of childhood-onset depressed mothers. J Child Psychol Psychiatry 2006;47:69-78.
64. Liu X, Buysse DJ, Gentzler AL, Kiss E, Mayer L, Kapornai K, Vetro A, Kovacs M: Insomnia and hypersomnia associated with depressive phenomenology and comorbidity in childhood depression. Sleep 2007;30:83-90.
65. Liu X, Gentzler AL, Tepper P, Kiss E, Kothencne VO, Tamas Z, Vetro A, Kovacs M: Clinical features of depressed children and adolescents with various forms of suicidality. J Clin Psychiatry 2006;67:1442-1450.
66. Kiss E, Gentzler AM, George C, Kapornai K, Tamas Z, Kovacs M, Vetro A: Factors influencing mother-child reports of depressive symptoms and agreement among clinically referred depressed youngsters in Hungary. J Affect Disord 2007;100:143-151.
67. Kapornai K, Gentzler AL, Tepper P, Kiss E, Mayer L, Tamas Z, Kovacs M, Vetro A: Early developmental characteristics and features of major depressive disorder among child psychiatric patients in Hungary. J Affect Disord 2007;100:91-101.
68. Tamas Z, Kovacs M, Gentzler AL, Tepper P, Gadoros J, Kiss E, Kapornai K, Vetro A: The relations of temperament and emotion self-regulation with suicidal behaviors in a clinical sample of depressed children in Hungary. J Abnorm Child Psychol 2007;35:640-652.
69. Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL: Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Am J Psychiatry 2001;158:125-127.
70. Strober M, Lampert C, Schmidt S, Morrell W: The course of major depressive disorder in adolescents. 1. Recovery and risk of manic switching in a follow-up of psychotic and nonpsychotic subtypes. J Am Acad Child Adolesc Psychiatry 1993;32:34-42.
71. Sherrill JT, Kovacs M: Interview schedule for children and adolescents (ISCA). J Am Acad Child Adolesc Psychiatry 2000;39:67-75.
72. Maziade M, Roy MA, Fournier JP, Cliche D, Merette C, Caron C, Garneau Y, Montgrain N, Shriqui C, Dion C, et al: Reliability of best-estimate diagnosis in genetic linkage studies of major psychoses: results from the Quebec pedigree studies. Am J Psychiatry 1992;149:1674-1686.
73. Kawaguchi Y, Tochimoto A, Hara M, Kawamoto M, Sugiura T, Saito S, Kamatani N: Contribution of single nucleotide polymorphisms of the IL1A gene to the cleavage of precursor IL-1α and its transcription activity. Immunogenetics 2007;59:441-448.
74. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
75. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS: The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 2001;412:99.
76. Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, Rafie-Kolpin M, Hsieh CM, Kornman KS, Duff GW: Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006;15:519-529.
77. Lind H, Haugen A, Zienolddiny S: Differential binding of proteins to the IL1B -31 T/C polymorphism in lung epithelial cells. Cytokine 2007;38:43-48.
78. Kimura R, Nishioka T, Soemantri A, Ishida T: Cis-acting effect of the IL1B C-31T polymorphism on IL-1β mRNA expression. Genes Immun 2004;5:572-575.
79. Chakravorty M, Ghosh A, Choudhury A, Santra A, Hembrum J, Roychoudhury S: Interaction between IL1B gene promoter polymorphisms in determining susceptibility to Helicobacter pylori associated duodenal ulcer. Hum Mutat 2006;27:411-419.
80. Rivera-Chavez FA, Peters-Hybki DL, Barber RC, O'Keefe GE: Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses. Shock 2003;20:218-223.
81. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-1376.
82. Abraham LJ, Kroeger KM: Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 1999;66:562-566.
83. Baseggio L, Bartholin L, Chantome A, Charlot C, Rimokh R, Salles G: Allele-specific binding to the -308 single nucleotide polymorphism site in the tumour necrosis factor-α promoter. Eur J Immunogenet 2004;31:15-19.
84. Kroeger KM, Steer JH, Joyce DA, Abraham LJ: Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine 2000;12:110-119.
85. Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, Maerker-Hermann E, Hoehler T: Different transcriptional activity and in vitro TNF-α production in psoriasis patients carrying the TNF-α 238A promoter polymorphism. J Invest Dermatol 2000;114:1180-1183.
86. van Heel DA, Udalova IA, De Silva AP, McGovern DP, Kinouchi Y, Hull J, Lench NJ, Cardon LR, Carey AH, Jewell DP, Kwiatkowski D: Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-κ-)B transcription factors. Hum Mol Genet 2002;11:1281-1289.
87. Hohjoh H, Tokunaga K: Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-α gene (TNFA) promoter. Genes Immun 2001;2:105-109.
88. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K: Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese. Tissue Antigens 1998;51:605-612.
89. Lv K, Chen R, Cai Q, Fang M, Sun S: Effects of a single nucleotide polymorphism on the expression of human tumor necrosis factor-α. Scand J Immunol 2006;64:164-169.
90. Rees LE, Wood NA, Gillespie KM, Lai KN, Gaston K, Mathieson PW: The interleukin-10 -1082 G/A polymorphism: allele frequency in different populations and functional significance. Cell Mol Life Sci 2002;59:560-569.
91. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P: Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999;42:1101-1108.
92. Steinke JW, Barekzi E, Hagman J, Borish L: Functional analysis of -571 IL-10 promoter polymorphism reveals a repressor element controlled by sp1. J Immunol 2004;173:3215-3222.
93. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW: Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993;91:403-404.
94. Vamvakopoulos JE, Taylor CJ, Morris-Stiff GJ, Green C, Metcalfe S: The interleukin-1 receptor antagonist gene: a single-copy variant of the intron 2 variable-number tandem repeat (VNTR) polymorphism. Eur J Immunogenet 2002;29:337-340.
95. Redlitz KH, Yamshchikov VF, Cominelli F: Differential contribution of IL-1Ra isoforms to allele-specific IL-1Ra mRNA accumulation. J Interferon Cytokine Res 2004;24:253-260.
96. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
97. Misener VL, Schachar R, Ickowicz A, Malone M, Roberts W, Tannock R, Kennedy JL, Pathare T, Barr CL: Replication test for association of the IL-1 receptor antagonist gene, IL1RN, with attention-deficit/hyperactivity disorder. Neuropsychobiology 2004;50:231-234.
98. Johnson VJ, Yucesoy B, Luster MI: Genotyping of single nucleotide polymorphisms in cytokine genes using real-time PCR allelic discrimination technology. Cytokine 2004;27:135-141.
99. Belfer I, Buzas B, Hipp H, Dean M, Evans C, Lorincz I, Max MB, Goldman D: Haplotype structure of inflammatory cytokines genes (IL1B, IL6 and TNF/LTA) in US Caucasians and African-Americans. Genes Immun 2004;5:505-512.
100. Laird NM, Horvath S, Xu X: Implementing a unified approach to family-based tests of association. Genet Epidemiol 2000;19(suppl 1):S36-S42.
101. Abecasis GR, Cherny SS, Cookson WO, Cardon LR: Merlin - rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002;30:97-101.
102. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
103. Sham PC, Curtis D: An extended transmission/disequilibrium test (TDT) for multiallele marker loci. Ann Hum Genet 1995;59:323-336.
104. Clayton D: A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 1999;65:1170-1177.
105. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1-8.
106. Meira-Lima IV, Pereira AC, Mota GF, Floriano M, Araujo F, Mansur AJ, Krieger JE, Vallada H: Analysis of a polymorphism in the promoter region of the tumor necrosis factor-α gene in schizophrenia and bipolar disorder: further support for an association with schizophrenia. Mol Psychiatry 2003;8:718-720.
107. Papiol S, Rosa A, Gutierrez B, Martin B, Salgado P, Catalan R, Arias B, Fananas L: Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder. J Med Genet 2004;41:219-223.
108. The International HapMap Consortium: The International HapMap Project. Nature 2003;426:789-796.
109. Dalal I, Karban A, Wine E, Eliakim R, Shirin H, Fridlender M, Shaoul R, Leshinsky-Silver E, Levine A: Polymorphisms in the TNF-α promoter and variability in the granulomatous response in patients with Crohn's disease. Pediatr Res 2006;59:825-828.
110. Deater-Deckard K, Reiss D, Hetherington EM, Plomin R: Dimensions and disorders of adolescent adjustment: a quantitative genetic analysis of unselected samples and selected extremes. J Child Psychol Psychiatry 1997;38:515-525.
111. Jun TY, Pae CU, Chae JH, Bahk WM, Kim KS, Han H: Report on IL-10 gene polymorphism at position -819 for major depression and schizophrenia in Korean population. Psychiatry Clin Neurosci 2002;56:177-180.
112. Hong CJ, Yu YW, Chen TJ, Tsai SJ: Interleukin-6 genetic polymorphism and Chinese major depression. Neuropsychobiology 2005;52:202-205.
113. Middle F, Jones I, Robertson E, Lendon C, Craddock N: Tumour necrosis factor-α and bipolar affective puerperal psychosis. Psychiatr Genet 2000;10:195-198.
114. Pae CU, Lee KU, Han H, Serretti A, Jun TY: Tumor necrosis factor-α gene-G308A polymorphism associated with bipolar I disorder in the Korean population. Psychiatry Res 2004;125:65-68.
115. Jun TY, Pae CU, Hoon H, Chae JH, Bahk WM, Kim KS, Serretti A: Possible association between -G308A tumour necrosis factor-α gene polymorphism and major depressive disorder in the Korean population. Psychiatr Genet 2003;13:179-181.
116. Rosa A, Peralta V, Papiol S, Cuesta MJ, Serrano F, Martinez-Larrea A, Fananas L: Interleukin-1β (IL-1β) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders. Am J Med Genet B Neuropsychiatr Genet 2004;124:10-14.
117. McCulley MC, Day IN, Holmes C: Association between interleukin 1-β promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2004;124:50-53.
118. Yu YW, Chen TJ, Hong CJ, Chen HM, Tsai SJ: Association study of the interleukin-1β (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology 2003;28:1182-1185.
119. Kim SJ, Lee HJ, Koo HG, Kim JW, Song JY, Kim MK, Shin DH, Jin SY, Hong MS, Park HJ, Yoon SH, Park HK, Chung JH: Impact of IL-1 receptor antagonist gene polymorphism on schizophrenia and bipolar disorder. Psychiatr Genet 2004;14:165-167.
120. Antonijevic IA: Depressive disorders - is it time to endorse different pathophysiologies? Psychoneuroendocrinology 2006;31:1-15.
121. O'Brien SM, Scully P, Scott LV, Dinan TG: Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord 2006;90:263-267.
122. Farmer A, Elkin A, McGuffin P: The genetics of bipolar affective disorder. Curr Opin Psychiatry 2007;20:8-12.
123. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A: The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 2003;60:497-502.